Added to YB: 2024-09-23
Pitch date: 2024-09-23
DNLI:US [bullish]
Denali Therapeutics Inc.
-42.66%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States.
Market Cap
$3.1B
Pitch Price
$30.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.70
P/E
-7.82
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Denali Therapeutics Inc. DNLI:US
A summary for this pitch has not been created yet.
Read full article (0 min)